During the past decade, Hembree Mercy Cancer Center at St. Edward Mercy Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 14 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hembree Mercy Cancer Center at St. Edward Mercy Medical Center" #1 sponsor was "SWOG Cancer Research Network" with 17 trials, followed by "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "M.D. Anderson Cancer Center" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "Eastern Cooperative Oncology Group" with 3 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hembree Mercy Cancer Center at St. Edward Mercy Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 34 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "NCIC Clinical Trials Group" with 6 trials as a collaborator, "Eastern Cooperative Oncology Group" with 5 trials as a collaborator and "SWOG Cancer Research Network" with 4 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Hembree Mercy Cancer Center at St. Edward Mercy Medical Center" are "Breast Cancer" (8 trials), "Lung Cancer" (5 trials), "Lymphoma" (4 trials), "Leukemia" (3 trials) and "Colorectal Cancer" (2 trials). Many other conditions were trialed in "Hembree Mercy Cancer Center at St. Edward Mercy Medical Center" in a lesser frequency.

Most popular intervention types in "Hembree Mercy Cancer Center at St. Edward Mercy Medical Center" are "Drug" (24 trials), "Biological" (11 trials), "Other" (11 trials), "Radiation" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (5 trials), "cyclophosphamide" (4 trials), "paclitaxel" (4 trials), "placebo" (4 trials) and "biologic sample preservation procedure" (3 trials). Other intervention names were less common.

The vast majority of trials in "Hembree Mercy Cancer Center at St. Edward Mercy Medical Center" are 25 trials for "All" genders, 7 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Hembree Mercy Cancer Center at St. Edward Mercy Medical Center". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 27 completed trials in Hembree Mercy Cancer Center at St. Edward Mercy Medical Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hembree Mercy Cancer Center at St. Edward Mercy Medical Center, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".